Clinical Trial

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label

Study acronym: SCENT-OL
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Smell dysfunction significantly impacts quality of life and safety, with limited effective treatments. This open-label study evaluates the preliminary efficacy of combining non-invasive trigeminal nerve stimulation (TNS) with standard smell training (ST) to improve olfactory function. Participants will complete 8 weeks of at-home treatment and attend three in-person visits for assessment. Improvements in smell, mood, sleep, and quality of life will be measured.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-13
Trial Details
NCT Number NCT07689773
Lead Sponsor Medical University of South Carolina
Conditions Olfactory Impairment
Enrollment 60 participants
Start Date 2026-07-10
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-12